Fc Gamma Receptor Proteins for Therapeutic Antibody Characterization
Fc gamma receptor proteins help researchers characterize how a therapeutic antibody’s Fc region interacts with activating and inhibitory receptors. A useful panel may include FcγRI/CD64, FcγRIIA/CD32a, FcγRIIB/CD32b and FcγRIIIA/CD16a, with relevant human variants or species orthologs selected according to the program. The right reagents should match the assay platform in species, extracellular-domain construct, tag, biotinylation status, purity and documented binding activity. This is a product-selection decision rather than a general Fc-receptor biology question. Researchers developing or comparing monoclonal antibodies, Fc-engineered antibodies, antibody–drug conjugates and biosimilar candidates may need receptor-specific binding data across more than one FcγR family member. Beta LifeScience offers an Fc receptor protein collection with recombinant and biotinylated formats for binding-assay development. Catalog products can be compared first, while specialized variants, additional orthologs and coordinated panel requirements can be submitted for technical evaluation.
Planning an Fc–FcγR characterization panel?
Share the antibody format, IgG subclass, required receptors, species, variants, assay platform, tags and estimated quantities. Beta LifeScience can help compare matching catalog products and evaluate coordinated semi-custom or custom formats.
Request Product Matching and a Quotation

Quick Guide: Which Fc Gamma Receptor Proteins Should You Compare?
|
Characterization requirement |
Receptor format to evaluate |
Purchasing pathway |
|
High-affinity Fc binding |
FcγRI/CD64 |
Compare active CD64 formats |
|
Activating FcγRII interaction |
FcγRIIA/CD32a, including relevant H167 or R167 variants |
Build a variant panel |
|
Inhibitory-receptor interaction |
FcγRIIB/CD32b |
Compare active CD32b formats |
|
ADCC-related Fc binding |
FcγRIIIA/CD16a, including relevant V158/F158 or V176/F176 numbering |
Compare catalog variants and formats |
|
Streptavidin-based immobilization |
Biotinylated receptor with documented biotinylation |
|
|
Human-to-model-species comparison |
Matched human and model-species FcγR proteins |
Coordinated catalog or custom panel |
|
Specialized construct or tag |
Semi-custom or custom receptor |
No single receptor represents the complete Fc-interaction profile. Panel composition should reflect the antibody’s mechanism, IgG subclass, Fc engineering, intended species and development question.
Featured Fc Gamma Receptor Proteins
The following products illustrate biotinylated FcγRI, FcγRII and FcγRIII formats for therapeutic-antibody binding studies. Numerical activity results apply to the test configuration documented on each product page and should be interpreted within the selected assay design.
|
Product |
Product family/catalog number |
Construct and format |
Expression and purity |
Representative documented activity |
Format to evaluate for |
|
BLK-02123P |
Gln16–Pro288; C-terminal His-Avi; biotinylated |
HEK293; >95% by Tris-Bis PAGE and HPLC |
SPR affinity constant of 0.91 nM in the documented test configuration |
High-affinity Fc binding and streptavidin-based assay development |
|
|
BLK-02406P |
Ala46–Pro217; C-terminal His-Avi; biotinylated |
HEK293; >95% by Tris-Bis PAGE and HPLC |
SPR affinity constant of 3.97 µM in the documented test configuration |
Inhibitory Fc-receptor binding studies |
|
|
BLK-02411P |
Human H167 variant; C-terminal His-Avi; biotinylated |
HEK293; review current product documentation |
Product-page activity data should be reviewed for the supplied configuration |
FcγRIIA H167 variant comparison |
|
|
BLK-02188P |
Human R167 variant; C-terminal His-Avi; biotinylated |
HEK293; review current product documentation |
Product-page activity data should be reviewed for the supplied configuration |
FcγRIIA R167 variant comparison |
|
|
BLK-02413P |
Human F176 variant; Gly17–Gln208; C-terminal His-Avi; biotinylated |
HEK293; >95% by Tris-Bis PAGE and HPLC |
ELISA EC50 of 35.7 ng/mL and SPR affinity of 0.14 µM in the product-page test configurations |
ADCC-related Fc binding and CD16a variant studies |
Ordering note: Product formats, pack sizes, pricing and availability may change. Pack-size SKUs may include a quantity suffix. Review each linked page and current lot documentation before purchasing.
Why source an FcγR panel through Beta LifeScience?
Compare receptor family, variant, species, sequence range, tag, biotinylation, purity and documented activity across catalog formats. Specialized receptors or coordinated panels can be submitted with aligned construct and QC requirements.

Match the Receptor Panel to the Antibody Question
FcγRI/CD64 for High-Affinity Fc Binding
FcγRI provides a high-affinity reference for comparing antibody lots, subclasses or Fc designs. Interpret results within the selected receptor format and assay configuration. Compare available CD64 proteins by species, tag, biotinylation status and activity documentation.
FcγRIIA/CD32a for Activating-Receptor and Variant Analysis
FcγRIIA is an activating receptor. H167 and R167 proteins allow controlled comparison of an antibody across receptor forms. Align constructs and assay conditions, and interpret apparent affinity differences within that configuration. For a CD32a panel, compare H167 and R167 formats under the same assay conditions.
FcγRIIB/CD32b for Inhibitory-Receptor Binding
FcγRIIB adds the inhibitory component to a panel containing relevant activating receptors. Because FcγRIIB and FcγRIIA are related but functionally distinct, confirm the exact target symbol, sequence and product identity. A CD32 label without the subtype is not sufficiently precise for purchasing. Compare CD32b alongside the activating receptors relevant to the antibody’s intended profile.
FcγRIIIA/CD16a for ADCC-Related Characterization
FcγRIIIA/CD16a is frequently evaluated in programs where Fc-mediated effector interaction is important. FcγRIIIA/CD16a polymorphism is commonly described as V158/F158 in mature-protein numbering and as V176/F176 in full-length precursor numbering. Product selection should follow the sequence numbering stated on the individual product page. Recombinant-protein binding assays can support molecular characterization, but they do not independently establish cellular ADCC performance. For functional interpretation, connect receptor-binding results with an appropriate cell-based assay. Keep the antibody concentration range, receptor loading and data-analysis model consistent across variants. Compare available CD16a variants and assay-ready formats by sequence, tag, biotinylation and documented activity. Specialized constructs or coordinated variant panels can also be submitted for technical evaluation.

Select a Format for SPR, BLI or Plate-Based Binding
Biotinylated and Avi-Tagged Receptors
Site-specific biotinylation can support controlled capture on streptavidin surfaces. Confirm that the protein is supplied as biotinylated; an Avi tag alone does not establish completed biotinylation. Review tag position and ensure the captured receptor retains access to its Fc-binding site.
His-Tagged Receptors
His-tagged receptors can support compatible capture and detection chemistries. When comparing a receptor panel, aligned tag position helps limit orientation differences. Confirm whether other assay components contain the same tag and could create detection ambiguity.
Fc-Tagged Receptors
An Fc fusion may complicate a study whose analyte is itself an antibody Fc. Use Fc-tagged receptor formats only when the assay design distinguishes the receptor fusion from the test antibody and controls Fc-mediated background.

Build a Comparable FcγR Binding Panel
Align extracellular domains, species, tags and expression systems whenever practical. Use the same antibody preparation, receptor loading, analyte ranges, buffers and fitting models across the panel. Include appropriate blank, negative and positive controls. Review sequence, purity, aggregation, biotinylation, endotoxin, formulation, activity documentation and lot-specific COAs according to the study requirements.
Applications in Therapeutic Antibody Characterization
FcγR protein panels may support:
- Comparison of lead antibodies or Fc-engineered variants
- IgG subclass and Fc-format assessment
- Activating-versus-inhibitory receptor profiling
- FcγRIIA and FcγRIIIA polymorphic-variant studies
- Biosimilar or lot-comparability research
- Human-versus-model-species cross-reactivity
- SPR, BLI, ELISA and other binding-assay development
Binding data provide one layer of characterization. Cell-based effector-function assays, target binding, structural attributes and other analytical measurements may also be needed according to the program.
Commercial Buying Considerations for an FcγR Panel
Define whether the study needs an initial screening panel or aligned comparability reagents. Estimate quantity from receptor loading, plates or flow cells, replicates, optimization and repeat studies. Request the datasheet, COA, purity image, activity data and biotinylation information required by the laboratory. Record antibody subclass, Fc mutations, glycosylation and aggregation alongside the receptor results. Purchasing note: Compare product specifications first, then request current pack sizes, availability, lead time and quotation for the complete panel. This supports a coordinated decision instead of sourcing each receptor without reference to the final assay design.
Choose a Catalog, Semi-Custom or Custom Fc Receptor Route
Recommended Purchasing Route
|
Requirement |
Suitable route |
|
Listed receptor, variant and tag match the assay |
Purchase a catalog protein |
|
Same receptor needed in another tag, quantity or formulation |
Request semi-custom production |
|
Specialized variant, ortholog or domain required |
Request custom protein expression |
|
Multiple aligned receptors required |
Submit a coordinated panel request |
For technical review, include:
- Antibody format, IgG subclass and Fc modifications
- Required FcγR subtypes, variants and species
- Assay platform and immobilization strategy
- Construct, tag and biotinylation requirements
- Purity, activity, endotoxin and formulation requirements
- Pilot and total quantities
- Required QC documents and delivery schedule
FAQs
Which Fc Gamma Receptors Should Be Included in an Antibody Panel?
The panel depends on mechanism and development stage. A broad human panel may include CD64, activating CD32a, inhibitory CD32b and CD16a, with relevant polymorphic variants.
Why Compare FcγRIIA H167 and R167 Variants?
The variants allow researchers to test whether an antibody’s interaction profile differs between the two receptor forms under a controlled assay configuration.
Are FcγR Binding Results the Same as ADCC Activity?
No. Recombinant-receptor binding characterizes a molecular interaction. ADCC is a cell-based functional outcome influenced by receptor expression, effector cells, target cells and assay conditions.
Should I Choose Biotinylated or His-Tagged Fc Receptors?
Choose the format that matches the capture and detection chemistry. Biotinylated Avi formats can support streptavidin capture, while His-tagged formats suit compatible anti-His or metal-chelate systems.
What Should I Verify Before Ordering Fc Receptor Proteins?
Confirm receptor subtype, variant, species, sequence, host, tag, biotinylation, purity, activity method, endotoxin, formulation, pack size, availability and lot documentation.
Compare Fc Gamma Receptor Proteins
Select FcγR proteins according to the therapeutic antibody’s mechanism and the assay decision. Build a panel that distinguishes high-affinity, activating and inhibitory interactions, then add polymorphic variants or species orthologs when relevant. Browse the Beta LifeScience Fc receptor collection to compare catalog formats. For specialized receptor variants or coordinated panels, submit the antibody and assay requirements for technical evaluation and quotation.